A Virginia biotech is close to securing a $3 million first round of funding before hitting the road in search of more money. Medgenics, which moved to Vienna from California in March after a struggle to survive, expects to close on nearly $2 million in mostly angel financing in the next month, adding to the $1 million it’s already raised.
